Imidocarb is a urea derivative used in veterinary medicine as an antiprotozoal agent for the treatment of infection with Babesia (babesiosis) and other parasites.[1][2][3]
Names | |
---|---|
Preferred IUPAC name
N,N′-Bis[3-(4,5-dihydro-1H-imidazol-2-yl)phenyl]urea | |
Other names
Imizocarb; Imizol; Diamidine
| |
Identifiers | |
3D model (JSmol)
|
|
ChemSpider | |
ECHA InfoCard | 100.044.268 |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C19H20N6O | |
Molar mass | 348.410 g·mol−1 |
Pharmacology | |
QP51EX01 (WHO) | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Mechanism of action
editImidocarb is anticholinergic; it inhibits acetylcholinesterase.[4][5]
References
edit- ^ Hashemi-Fesharki, R (1977). "Studies on imidocarb dihydrochloride in experimental Babesia ovis infection in splenectomized lambs". The British Veterinary Journal. 133 (6): 609–14. doi:10.1016/S0007-1935(17)33941-6. PMID 608109.
- ^ Hashemi-Fesharki, R (1975). "Studies on imidocarb dihydrochloride in experimental Babesia bigemina infection in calves". The British Veterinary Journal. 131 (6): 666–72. doi:10.1016/S0007-1935(17)35138-2. PMID 1212605.
- ^ Kuttler, KL (1980). "Pharmacotherapeutics of drugs used in treatment of anaplasmosis and babesiosis". Journal of the American Veterinary Medical Association. 176 (10 Spec No): 1103–8. PMID 7216881.
- ^ "Imidocarb". DrugBank. Retrieved November 23, 2024.
- ^ Papich, Mark G. (2016). Saunders Handbook of Veterinary Drugs (4th ed.). Elsevier. pp. 391–392. doi:10.1016/B978-0-323-24485-5.00304-1. ISBN 978-0-323-24485-5.